Literature DB >> 16896655

Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke.

M Meaney1, J Allister, B McKinstry, K McLaughlin, G P Brennan, A B Forbes, I Fairweather.   

Abstract

A study has been carried out to investigate the morphological effects of half-strength triclabendazole (TCBZ), half-strength clorsulon, and a combination of these two drugs against mature Fasciola hepatica. The Cullompton TCBZ-susceptible isolate was used for these experiments. Flukes were incubated for 24 h in vitro in TCBZ sulphoxide (7.5 microg/ml), clorsulon (5 microg/ml), or a combination of the two drugs. For the in vivo experiment, rats were dosed with TCBZ (6.25 mg/kg body weight), clorsulon (5 mg/kg body weight), or a combination of the two drugs and flukes recovered after 48 h. Surface changes to the flukes were assessed by scanning electron microscopy. Treatment with the combination of drugs produced greater disruption to the flukes than the individual drugs at half-strength, both in vivo and in vitro. Disruption to the tegument of the flukes induced by the individual drugs at half-strength was relatively minor and less than that caused by the drugs at full-strength. The results suggest that there are additive effects between TCBZ and clorsulon, which may be indicative of synergy: the use of drug combinations would be of value in the treatment of triclabendazole-resistant fluke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896655     DOI: 10.1007/s00436-006-0222-z

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  25 in total

Review 1.  Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.

Authors:  Jürg Utzinger; Jennifer Keiser; Xiao Shuhua; Marcel Tanner; Burton H Singer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  A light and electron microscopic study on the synergistic effect of pyrantel and the febantel metabolite febendazole on adult Toxocara canis in vitro.

Authors:  Heinz Mehlhorn; Elena Hanser; Achim Harder; O Hansen; Norbert Mencke; Roland Schaper
Journal:  Parasitol Res       Date:  2003-04-01       Impact factor: 2.289

Review 3.  Drug resistance in veterinary helminths.

Authors:  Adrian J Wolstenholme; Ian Fairweather; Roger Prichard; Georg von Samson-Himmelstjerna; Nicholas C Sangster
Journal:  Trends Parasitol       Date:  2004-10

Review 4.  Triclabendazole: new skills to unravel an old(ish) enigma.

Authors:  I Fairweather
Journal:  J Helminthol       Date:  2005-09       Impact factor: 2.170

Review 5.  Anthelmintic resistance.

Authors:  P J Waller
Journal:  Vet Parasitol       Date:  1997-11       Impact factor: 2.738

6.  Effects of mebendazole and levamisole on tetrathyridia of Mesocestoides corti in the mouse.

Authors:  E M Bennet; C Behm; C Bryant
Journal:  Int J Parasitol       Date:  1978-12       Impact factor: 3.981

7.  A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica.

Authors:  M Meaney; S Haughey; G P Brennan; I Fairweather
Journal:  Parasitol Res       Date:  2004-12-10       Impact factor: 2.289

8.  Could ivermectin have a synergic effect with albendazole in hydatidosis therapy?

Authors:  N Casado; M J Moreno; M A Urrea-París; F Rodríguez-Caabeiro
Journal:  Parasitol Res       Date:  2002-02       Impact factor: 2.289

9.  The kinetics of triclabendazole disposition in sheep.

Authors:  D R Hennessy; E Lacey; J W Steel; R K Prichard
Journal:  J Vet Pharmacol Ther       Date:  1987-03       Impact factor: 1.786

Review 10.  Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control.

Authors:  Jürg Utzinger; Jennifer Keiser
Journal:  Expert Opin Pharmacother       Date:  2004-02       Impact factor: 3.889

View more
  9 in total

1.  Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.

Authors:  Catherine Devine; Gerard P Brennan; Carlos E Lanusse; Luis I Alvarez; Alan Trudgett; Elizabeth Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2010-03-25       Impact factor: 2.289

2.  Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).

Authors:  B McKinstry; G P Brennan; L Halferty; A B Forbes; I Fairweather
Journal:  Parasitol Res       Date:  2007-06-08       Impact factor: 2.289

3.  Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.

Authors:  M McConville; G P Brennan; A Flanagan; R E B Hanna; H W J Edgar; R Castillo; A Hernández-Campos; I Fairweather
Journal:  Parasitol Res       Date:  2009-05-21       Impact factor: 2.289

4.  Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha.

Authors:  Maeve McConville; Robert E B Hanna; Gerard P Brennan; Maurice McCoy; Hillary W J Edgar; Shirley McConnell; Rafael Castillo; Alicia Hernández-Campos; Ian Fairweather
Journal:  Parasitol Res       Date:  2009-11-18       Impact factor: 2.289

5.  In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78.

Authors:  Urs Duthaler; Thomas A Smith; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

6.  Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.

Authors:  M Meaney; J Allister; B McKinstry; K McLaughlin; G P Brennan; A B Forbes; I Fairweather
Journal:  Parasitol Res       Date:  2006-12-19       Impact factor: 2.289

7.  Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole.

Authors:  Catherine Devine; Gerard P Brennan; Carlos E Lanusse; Luis I Alvarez; Alan Trudgett; Elizabeth Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2010-05-30       Impact factor: 2.289

8.  Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax).

Authors:  B McKinstry; L Halferty; G P Brennan; I Fairweather
Journal:  Parasitol Res       Date:  2008-11-18       Impact factor: 2.289

Review 9.  Drug resistance in liver flukes.

Authors:  I Fairweather; G P Brennan; R E B Hanna; M W Robinson; P J Skuce
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-01-10       Impact factor: 4.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.